Selected research
Market Structure
Global Danshen Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Danshen Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Danshen Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Danshen Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Danshen Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Danshen Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Danshen Injection include Changshu Leiyunshang Pharmaceutical, Fujian Gutian Pharmaceutical, Shineway Pharmaceutical, Langch Group, Green Valley Pharma, Sunnyhope Pharmaceutical, HuiKang Pharmaceutical and CHIATAI QINGCHUNBAO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Danshen Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Danshen Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Danshen Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Danshen Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Danshen Injection Segment by Company
Changshu Leiyunshang Pharmaceutical
Fujian Gutian Pharmaceutical
Shineway Pharmaceutical
Langch Group
Green Valley Pharma
Sunnyhope Pharmaceutical
HuiKang Pharmaceutical
CHIATAI QINGCHUNBAO
Danshen Injection Segment by Type
2ml Per Tube
10ml Per Tube
Danshen Injection Segment by Application
Tertiary Hospital
Secondary Hospital
Others
Danshen Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Danshen Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Danshen Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Danshen Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Danshen Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Danshen Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Danshen Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Danshen Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 2ml Per Tube
- 10ml Per Tube
Applications
- Tertiary Hospital
- Secondary Hospital
- Others
Companies covered
- Changshu Leiyunshang Pharmaceutical
- Fujian Gutian Pharmaceutical
- Shineway Pharmaceutical
- Langch Group
- Green Valley Pharma
- Sunnyhope Pharmaceutical
- HuiKang Pharmaceutical
- CHIATAI QINGCHUNBAO
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Danshen Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Danshen Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Danshen Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Danshen Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Danshen Injection Market Dynamics
- 2.1 Danshen Injection Industry Trends
- 2.2 Danshen Injection Industry Drivers
- 2.3 Danshen Injection Industry Opportunities and Challenges
- 2.4 Danshen Injection Industry Restraints
3 Danshen Injection Market by Manufacturers
- 3.1 Global Danshen Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Danshen Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Danshen Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Danshen Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Danshen Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Danshen Injection Manufacturers, Product Type & Application
- 3.7 Global Danshen Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Danshen Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Danshen Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Danshen Injection Tier 1, Tier 2, and Tier 3
4 Danshen Injection Market by Type
- 4.1 Danshen Injection Type Introduction
- 4.1.1 2ml Per Tube
- 4.1.2 10ml Per Tube
- 4.2 Global Danshen Injection Sales by Type
- 4.2.1 Global Danshen Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Danshen Injection Sales by Type (2021-2032)
- 4.2.3 Global Danshen Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Danshen Injection Revenue by Type
- 4.3.1 Global Danshen Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Danshen Injection Revenue by Type (2021-2032)
- 4.3.3 Global Danshen Injection Revenue Market Share by Type (2021-2032)
5 Danshen Injection Market by Application
- 5.1 Danshen Injection Application Introduction
- 5.1.1 Tertiary Hospital
- 5.1.2 Secondary Hospital
- 5.1.3 Others
- 5.2 Global Danshen Injection Sales by Application
- 5.2.1 Global Danshen Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Danshen Injection Sales by Application (2021-2032)
- 5.2.3 Global Danshen Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Danshen Injection Revenue by Application
- 5.3.1 Global Danshen Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Danshen Injection Revenue by Application (2021-2032)
- 5.3.3 Global Danshen Injection Revenue Market Share by Application (2021-2032)
6 Global Danshen Injection Sales by Region
- 6.1 Global Danshen Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Danshen Injection Sales by Region (2021-2032)
- 6.2.1 Global Danshen Injection Sales by Region (2021-2026)
- 6.2.2 Global Danshen Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Danshen Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Danshen Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Danshen Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Danshen Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Danshen Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Danshen Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Danshen Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Danshen Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Danshen Injection Revenue by Region
- 7.1 Global Danshen Injection Revenue by Region
- 7.1.1 Global Danshen Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Danshen Injection Revenue by Region (2021-2026)
- 7.1.3 Global Danshen Injection Revenue by Region (2027-2032)
- 7.1.4 Global Danshen Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Danshen Injection Revenue (2021-2032)
- 7.2.2 North America Danshen Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Danshen Injection Revenue (2021-2032)
- 7.3.2 Europe Danshen Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Danshen Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Danshen Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Danshen Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Danshen Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Changshu Leiyunshang Pharmaceutical
- 8.1.1 Changshu Leiyunshang Pharmaceutical Company Information
- 8.1.2 Changshu Leiyunshang Pharmaceutical Business Overview
- 8.1.3 Changshu Leiyunshang Pharmaceutical Danshen Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Changshu Leiyunshang Pharmaceutical Danshen Injection Product Portfolio
- 8.1.5 Changshu Leiyunshang Pharmaceutical Recent Developments
- 8.2 Fujian Gutian Pharmaceutical
- 8.2.1 Fujian Gutian Pharmaceutical Company Information
- 8.2.2 Fujian Gutian Pharmaceutical Business Overview
- 8.2.3 Fujian Gutian Pharmaceutical Danshen Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Fujian Gutian Pharmaceutical Danshen Injection Product Portfolio
- 8.2.5 Fujian Gutian Pharmaceutical Recent Developments
- 8.3 Shineway Pharmaceutical
- 8.3.1 Shineway Pharmaceutical Company Information
- 8.3.2 Shineway Pharmaceutical Business Overview
- 8.3.3 Shineway Pharmaceutical Danshen Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shineway Pharmaceutical Danshen Injection Product Portfolio
- 8.3.5 Shineway Pharmaceutical Recent Developments
- 8.4 Langch Group
- 8.4.1 Langch Group Company Information
- 8.4.2 Langch Group Business Overview
- 8.4.3 Langch Group Danshen Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Langch Group Danshen Injection Product Portfolio
- 8.4.5 Langch Group Recent Developments
- 8.5 Green Valley Pharma
- 8.5.1 Green Valley Pharma Company Information
- 8.5.2 Green Valley Pharma Business Overview
- 8.5.3 Green Valley Pharma Danshen Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Green Valley Pharma Danshen Injection Product Portfolio
- 8.5.5 Green Valley Pharma Recent Developments
- 8.6 Sunnyhope Pharmaceutical
- 8.6.1 Sunnyhope Pharmaceutical Company Information
- 8.6.2 Sunnyhope Pharmaceutical Business Overview
- 8.6.3 Sunnyhope Pharmaceutical Danshen Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sunnyhope Pharmaceutical Danshen Injection Product Portfolio
- 8.6.5 Sunnyhope Pharmaceutical Recent Developments
- 8.7 HuiKang Pharmaceutical
- 8.7.1 HuiKang Pharmaceutical Company Information
- 8.7.2 HuiKang Pharmaceutical Business Overview
- 8.7.3 HuiKang Pharmaceutical Danshen Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 HuiKang Pharmaceutical Danshen Injection Product Portfolio
- 8.7.5 HuiKang Pharmaceutical Recent Developments
- 8.8 CHIATAI QINGCHUNBAO
- 8.8.1 CHIATAI QINGCHUNBAO Company Information
- 8.8.2 CHIATAI QINGCHUNBAO Business Overview
- 8.8.3 CHIATAI QINGCHUNBAO Danshen Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 CHIATAI QINGCHUNBAO Danshen Injection Product Portfolio
- 8.8.5 CHIATAI QINGCHUNBAO Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Danshen Injection Value Chain Analysis
- 9.1.1 Danshen Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Danshen Injection Production Mode & Process
- 9.2 Danshen Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Danshen Injection Distributors
- 9.2.3 Danshen Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst